The Joe Rogan Experience

Podbit · The Joe Rogan Experience

#2537 - David Sinclair

Explore episode Aug 7, 2026
Health & Fitness
GLP-1 Drugs Are Doubling Rates of Sudden Blindness

#2537 - David Sinclair · Aug 7, 2026 Health & Fitness

Since GLP-1 drugs like Ozempic became widespread, rates of NION (non-arteritic ischemic optic neuropathy) — a sudden, painless, potentially permanent loss of vision in one eye — have doubled. Users appear to be 68.6 times more likely to develop this condition.

Where this was said

GLP-1 Drugs, Sudden Blindness, and the Problem with Hype

At 55:30 · chapter starts 49:10

The conversation takes a timely and controversial turn when Sinclair reveals that his age-reversal eye therapy is currently also targeting NION — a condition whose rates, he says, have doubled since GLP-1 drugs became popular. Citing Harvard researcher Joe Rizzo, Sinclair says the correlation is robust and global. Rogan reads alarming statistics from Perplexity suggesting a 68.6-times increased risk for GLP-1 users. Both acknowledge that absolute risk remains low and that these drugs have likely saved millions of lives through weight loss and metabolic health improvements. But Sinclair's warning is clear: these drugs are not without risk, and the enthusiastic online promotion of Ozempic by people with financial interests in the drugs is doing the public a disservice. The segment is a model of nuanced thinking about pharmaceutical trade-offs.

Health & Fitness
Tadalafil (7mg/day) may prevent cancer

#2537 - David Sinclair · Aug 7, 2026

A recent study found that tadalafil (Cialis), taken at 7mg daily, appears to protect mice and humans against certain cancers including head and neck cancer by exposing tumors to the immune system.

Health & Fitness
GLP-1 blindness risk 68.6x higher

#2537 - David Sinclair · Aug 7, 2026

Users of GLP-1 drugs like Ozempic appear to be 68.6 times more likely to develop sudden vision loss (NION), and rates of this eye condition have doubled since these drugs became widespread.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.